The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Professional NewsFull Access

Next Steps

The OIG recommends that the following steps be taken by the Centers for Medicare and Medicaid Services to prevent inappropriately prescribed medications and noncompliance with Medicare rules:

  • Facilitate access to information necessary to ensure accurate coverage and reimbursement determinations.

  • Assess whether survey and certification processes for nursing home licensure offer adequate safeguards against unnecessary antipsychotic medication use in nursing homes.

  • Explore alternative methods beyond survey and certification processes to promote compliance with federal standards regarding unnecessary drug use in nursing homes.

  • Take appropriate action regarding the claims associated with erroneous payments identified in the OIG sample.